Loading...

DBVT DBV TECHNOLOGIES SA Earnings Reports 8-K Filing

DBV

DBVT

DBV TECHNOLOGIES SA

(DBVT)

2025 8-K

Show Summary

Summary

New Product Launches

Compensatory Arrangements o...

Financial Statements

Private Placement

Financial Results

Positive Study Results

Management Changes

Nasdaq Compliance

FDA Approval Pathway

ADS Ratio Change

Financial Results

Financial Update

Clinical Trial Update

Earnings Report

Ratio Change Announcement

Ratio Change of ADSs

Amendments to Bylaws and Sh...

Earnings Report

Financial Results and Busin...

Appointment of CFO

Amendment to Form 8-K/A

Termination of Agreement

Appointment of CFO and Depa...

Earnings Report

Publication of Phase 3 EPIT...

Earnings Report

Financial Condition and Oth...

Annual General Meeting

Regulation FD Disclosure

Clinical Trial Announcement

Financial Results Announcement

External Links:

On March 24, 2025, DBV Technologies S.A. announced preliminary unaudited financial results for the fiscal year ending December 31, 2024, which are subject to change and do not fully represent the company's financial condition.

AI Assistant

DBV TECHNOLOGIES SA

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.